‘Injury-healing pill’ that halts naturally degenerative effects of aging? US Defense Department launches human performance nutraceutical tests

Print Friendly, PDF & Email
Credit: Tech. Sgt. Christopher Hubenthal/US Air Force
Credit: Tech. Sgt. Christopher Hubenthal/US Air Force

U.S. Special Operations Command (SOCOM), the organization that administers America’s Spec Ops forces, says it will soon start clinical trials of an “anti-aging pill” that could halt some naturally degenerative effects of aging.

The pill involves what [Navy Commander Tim] Hawkins called a “human performance small molecule” [called NAD+] that will be fashioned into a nutraceutical form for both civilians and military personnel. He continued:

These efforts are not about creating physical traits that don’t already exist naturally. This is about enhancing the mission readiness of our forces by improving performance characteristics that typically decline with age. Essentially, we are working with leading industry partners and clinical research institutions to develop a nutraceutical, in the form of a pill that is suitable for a variety of uses by both civilians and military members.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

MetroBiotech [claims] the tech could help slow neurodegeneration, decrease inflammation in the body, increase “cardioprotection,” and more.

Read the original post

Related article:  3 ways artificial intelligence is tackling cancer
Outbreak Featured
Infographic: Growing human embryos — How long should researchers watch human development play out in a dish?

Infographic: Growing human embryos — How long should researchers watch human development play out in a dish?

In May, the International Society for Stem Cell Research (ISSCR) released new guidelines that relaxed the 14-day rule, taking away ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.